Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $11.15 billion. The enterprise value is $10.84 billion.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 159.39 million shares outstanding. The number of shares has increased by 7.96% in one year.
| Current Share Class | 159.39M |
| Shares Outstanding | 159.39M |
| Shares Change (YoY) | +7.96% |
| Shares Change (QoQ) | +14.87% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 106.03% |
| Float | 158.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.57 |
| Forward PS | 16.53 |
| PB Ratio | 17.63 |
| P/TBV Ratio | 17.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 3.14.
| Current Ratio | 2.87 |
| Quick Ratio | 2.61 |
| Debt / Equity | 3.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.92 |
Financial Efficiency
Return on equity (ROE) is -59.91% and return on invested capital (ROIC) is -6.85%.
| Return on Equity (ROE) | -59.91% |
| Return on Assets (ROA) | -5.87% |
| Return on Invested Capital (ROIC) | -6.85% |
| Return on Capital Employed (ROCE) | -12.77% |
| Revenue Per Employee | $883,115 |
| Profits Per Employee | -$250,904 |
| Employee Count | 1,069 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 48.06 |
Taxes
| Income Tax | -6.22M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.84% in the last 52 weeks. The beta is 0.33, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +83.84% |
| 50-Day Moving Average | 54.98 |
| 200-Day Moving Average | 39.42 |
| Relative Strength Index (RSI) | 79.22 |
| Average Volume (20 Days) | 2,129,119 |
Short Selling Information
The latest short interest is 12.28 million, so 7.70% of the outstanding shares have been sold short.
| Short Interest | 12.28M |
| Short Previous Month | 11.97M |
| Short % of Shares Out | 7.70% |
| Short % of Float | 7.77% |
| Short Ratio (days to cover) | 3.69 |
Income Statement
In the last 12 months, IONS had revenue of $944.05 million and -$268.22 million in losses. Loss per share was -$1.73.
| Revenue | 944.05M |
| Gross Profit | 50.07M |
| Operating Income | -266.52M |
| Pretax Income | -274.43M |
| Net Income | -268.22M |
| EBITDA | -255.17M |
| EBIT | -266.52M |
| Loss Per Share | -$1.73 |
Full Income StatementBalance Sheet
The company has $2.29 billion in cash and $1.98 billion in debt, giving a net cash position of $308.97 million or $1.94 per share.
| Cash & Cash Equivalents | 2.29B |
| Total Debt | 1.98B |
| Net Cash | 308.97M |
| Net Cash Per Share | $1.94 |
| Equity (Book Value) | 631.72M |
| Book Value Per Share | 3.97 |
| Working Capital | 1.68B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$230.57 million and capital expenditures -$59.44 million, giving a free cash flow of -$290.00 million.
| Operating Cash Flow | -230.57M |
| Capital Expenditures | -59.44M |
| Free Cash Flow | -290.00M |
| FCF Per Share | -$1.82 |
Full Cash Flow StatementMargins
Gross margin is 5.30%, with operating and profit margins of -28.23% and -28.41%.
| Gross Margin | 5.30% |
| Operating Margin | -28.23% |
| Pretax Margin | -29.07% |
| Profit Margin | -28.41% |
| EBITDA Margin | -27.03% |
| EBIT Margin | -28.23% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.95% |
| Shareholder Yield | -7.95% |
| Earnings Yield | -2.40% |
| FCF Yield | -2.60% |
Dividend DetailsAnalyst Forecast
The average price target for IONS is $75.35, which is 7.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $75.35 |
| Price Target Difference | 7.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 28.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.11 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.11 |
| Piotroski F-Score | 4 |
